Q&A With Precision’s Scott Marshall in Drug Discovery & Development: Biomarkers Can Inform Early-Stage Clinical Trial Design

 

Precision for Medicine’s Scott Marshall, managing director, Translational Informatics & Diagnostics, participates in a Q&A with Drug Discovery & Development’s Ryan Bushey. Marshall outlines the benefits biomarkers can yield in early-stage trials.

To read the complete interview, click here.